Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M. El Sahly, Jacqueline M. Miller, Lindsey R. Baden et al.|New England Journal of Medicine|2021Cited by 661
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Kuleni Abebe, Nadine Rouphael et al.|Nature Medicine|2023Cited by 56
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patientsJoann Diray‐Arce, Sidney Carrillo, Slim Fourati et al.|Cell Reports Medicine|2023Cited by 53
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phasesLindsey R. Baden, Jacqueline M. Miller, Hana M. El Sahly et al.|Nature Communications|2024Cited by 35
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Kuleni Abebe, Nadine Rouphael et al.|medRxiv|2022Cited by 30